BCL9L expression in 60 paired OS and peritumor tissues was measured by qRT-PCR and Western blotting, and the expression level of BCL9L was significantly more in tumor than in peritumor tissues (P < 0.05, Figures 4B,D). This evidence concerns the gene BCL9L and neoplasm.